Valuation: Healius Limited

Market Cap 280M 193M 169M 156M 145M 274M 18.5B 1.88B 731M 9.06B 726M 710M 31.43B P/E 2026 *
-10.1x
P/E 2027 * -108x
Enterprise Value 1.19B 821M 720M 665M 614M 1.16B 78.58B 7.99B 3.1B 38.46B 3.08B 3.01B 133B EV / Sales 2026 *
0.86x
EV / Sales 2027 * 0.85x
Free-Float
77.51%
Yield 2026 *
-
Yield 2027 * 0.35%
1 week-1.28%
Current month-1.28%
1 month+18.46%
3 months-24.51%
6 months-59.47%
Current year-57.46%
1 week 0.37
Extreme 0.367
0.4
1 month 0.3
Extreme 0.3
0.42
Current year 0.3
Extreme 0.3
1.05
1 year 0.3
Extreme 0.3
1.07
3 years 0.3
Extreme 0.3
3.08
5 years 0.3
Extreme 0.3
5.54
10 years 0.3
Extreme 0.3
5.54
Manager TitleAgeSince
Chief Executive Officer - 2024-03-04
Director of Finance/CFO - 2025-10-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2018-08-20
Chairman 65 2023-11-27
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
04-21Fiscal year

Director

22,978 0.0032%
03-12Buy

Director

8,547 0.0012%
03-11Buy

Director

130,000 0.0179%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.28%-47.26%-87.29% 194M
-2.45%-0.68%+73.14%+467.98% 40.28B
-2.16%-2.16%+7.88%+31.96% 23.28B
-0.05%+5.00%-19.04%-36.81% 7.49B
-3.30%-0.05%+18.56%+106.84% 5.33B
-1.62%+0.44%+15.84%+40.15% 2.96B
+0.31%-8.49%-23.00%+972.22% 1.94B
-1.79%-4.88%+91.14%-16.04% 1.89B
+0.16%-0.16%+29.03%-24.86% 1.68B
+0.06%-0.45%+19.27%-4.40% 1.64B
Average -1.12%+0.88%+16.56%+144.97% 8.67B
Weighted average by Cap. -2.16%+2.92%+38.43%+251.48%

Financials

2026 *2027 *
Net sales 1.38B 953M 836M 772M 713M 1.35B 91.23B 9.28B 3.6B 44.65B 3.58B 3.5B 155B 1.43B 985M 864M 798M 737M 1.4B 94.36B 9.59B 3.73B 46.18B 3.7B 3.62B 160B
Net income -27.1M -18.73M -16.43M -15.17M -14.02M -26.56M -1.79B -182M -70.84M -878M -70.34M -68.8M -3.05B -2.05M -1.42M -1.25M -1.15M -1.06M -2.01M -136M -13.82M -5.37M -66.53M -5.33M -5.21M -231M
Net Debt 908M 627M 550M 508M 470M 890M 60.08B 6.11B 2.37B 29.4B 2.36B 2.3B 102B 930M 643M 564M 520M 481M 911M 61.53B 6.26B 2.43B 30.11B 2.41B 2.36B 105B
Logo Healius Limited
Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.
Employees
5,962
Date Price Change Volume
26-07-08 A$0.3850 0.00% 2,087,690
26-07-07 A$0.3850 0.00% 2,657,093
26-07-06 A$0.3850 +2.67% 1,999,609
26-07-03 A$0.3750 -1.32% 715,221
26-07-02 A$0.3800 +2.70% 2,371,796
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
10
Last Close Price
0.3850AUD
Average target price
0.5142AUD
Spread / Average Target
+33.55%

Quarterly revenue - Rate of surprise